Human papillomaviruses as therapeutic targets in human cancer.
about
The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapyPathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapiesDiagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin-proteasome system.Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis--an observational cohort study.Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal modelIntracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.Therapeutic Vaccine Strategies against Human Papillomavirus.Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesRecent advances in understanding and preventing human papillomavirus-related disease.Novel targeted therapies for the treatment of penile cancer.Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises.Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.Expression, Polyubiquitination, and Therapeutic Potential of Recombinant E6E7 from HPV16 Antigens Fused to Ubiquitin.Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer.Detection of human Papillomavirus in biopsies of patients with cervical cancer, and its association with prognosis.Inhibition of TGF-β and NOTCH Signaling by Cutaneous Papillomaviruses.Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.The Impact of HPV as an Etiological Factor in Gynecological and Oropharyngeal CancerHuman papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretionA Review of HPV-Related Head and Neck Cancer
P2860
Q26744087-62F39DE7-C1B6-4E26-8426-D4F2D4D5B447Q26744446-4C44612A-B27A-4C92-81F0-9ADCABF36A73Q30241076-7FDE049D-B2EF-47D4-8D8D-8B0E68BDD7C3Q34662232-61945D5A-0D79-49B0-99E8-9BB1BDB5B739Q34802753-67784A92-F975-4161-A772-26C4810E26C5Q35061200-F584F23D-CE9A-4A94-8C4C-5DB5366A179CQ35685208-3CA7C929-7521-4AAD-BA87-CC1A4974077CQ35826752-90AE93FD-F62A-4337-A52C-5FF777CDF1AFQ37494787-CBAA44F0-0776-4711-B79F-21C375BFF59FQ37709706-F1303EB3-8C80-4A70-BF0B-9CEA7ED3221FQ38217530-132112C9-3B35-4A64-8676-907BACA7DD3DQ38692795-96AFB167-C9AC-4E10-9A35-AA3744822F3CQ38824314-84341DC5-F210-41DB-92CE-6C33F44B82C3Q38979885-80BF0280-2EB7-420A-9779-761FC34785D4Q40091492-85082E08-CB72-47FE-9788-264A620A4D2BQ40367504-07709146-3F61-4E07-B2B1-D549E35BDFECQ40394482-ECC6277E-1FAA-4120-8E55-83CB133D5038Q53093760-F95C7C31-9DBF-4696-82D1-B45F2F6A5867Q53113509-4F4B5597-5192-4760-A24E-7F3E5D7B794FQ54250476-3186E7BD-5E24-44C9-A3CA-CA1DD590ABC3Q55086081-9084529A-4F90-46E3-9745-535257994054Q57028715-471DA34A-637E-4969-9C79-C15680EB6AA4Q57580316-33FDD7E3-93C4-4A15-8C7A-C22FC4A829E1Q58700166-3B9CD7BE-F671-4E28-9658-F52B09BC2B08
P2860
Human papillomaviruses as therapeutic targets in human cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Human papillomaviruses as therapeutic targets in human cancer.
@en
type
label
Human papillomaviruses as therapeutic targets in human cancer.
@en
prefLabel
Human papillomaviruses as therapeutic targets in human cancer.
@en
P2860
P356
P1476
Human papillomaviruses as therapeutic targets in human cancer.
@en
P2093
Karin Hellner
Karl Münger
P2860
P304
P356
10.1200/JCO.2010.28.2186
P407
P577
2011-01-10T00:00:00Z